EMEA Expansion Leverage the recent appointment of a VP/GM for EMEA to accelerate market entry and expansion in Europe, focusing on urology departments, cancer centers, and hospital procurement with a tailored value proposition around Blue Light Cystoscopy with Cysview.

Medtech Partnerships Explore joint business opportunities with imaging and cystoscope manufacturers (Richard Wolf, Karl Storz) to bundle advanced blue light cystoscopy with next-generation HD cystoscopes, creating bundled offerings for hospitals and ambulatory centers, supported by co-marketing and co-sales programs.

Global Access Programs Assess opportunities to expand Named Patient Programs into additional regions with licensing barriers to rapidly provide Hexvix/Cysview in underserved markets, while building local awareness and clinician education through thought-leadership and case studies.

Clinical Adoption Target non-muscle-invasive bladder cancer pathways by highlighting evidence from conferences and studies showing improved tumor detection with blue light cystoscopy, coupling this with payer discussions and outcome-based value messaging.

Channel and CRM Maximize the existing tech stack and partnerships by building a robust global distributor and direct-sales channel, supported by Salesforce-driven demand generation, training, and after-sales support to ensure wide adoption in outpatient and hospital settings.